A clinical evaluation of patients with known mutations (plasminogen and factor XII) with a focus on prophylactic treatment

A clinical evaluation of patients with known mutations (plasminogen and factor XII) with a focus on prophylactic treatment

AbstractBackground Hereditary angioedema with normal C1-inhibitor (HAE-nC1-INH) is a rare genetic disease. The symptoms can resemble other forms of hereditary angioedema (HAE), but the specific laboratory values are inconspicuous. The knowledge about treatment strategies in HAE-nC1-INH remains insuf...

Full description

Bibliographic Details
Main Authors: Robin Lochbaum, Susanne Trainotti, Thomas K. Hoffmann, Jens Greve, Janina Hahn
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Journal of Dermatological Treatment
Subjects:
Hereditary angioedema
HAE-nC1-INH
C1-inhibitor
prophylaxis
treatment
mutation
Online Access:https://www.tandfonline.com/doi/10.1080/09546634.2023.2290362

Internet

https://www.tandfonline.com/doi/10.1080/09546634.2023.2290362

Similar Items